These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 15646090

  • 1. Are angiotensin-receptor blockers (ARBs) equivalent to or better than angiotensin-converting enzyme (ACE) inhibitors in the treatment of heart failure?
    Reigle J.
    Crit Care Nurse; 2004 Dec; 24(6):67-9. PubMed ID: 15646090
    [No Abstract] [Full Text] [Related]

  • 2. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA, Movahed A.
    Rev Cardiovasc Med; 2005 Dec; 6(4):206-13. PubMed ID: 16379016
    [Abstract] [Full Text] [Related]

  • 3. The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.
    Sica DA.
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):66-71. PubMed ID: 12228845
    [Abstract] [Full Text] [Related]

  • 4. Progress in the development of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Singh RK, Barker S.
    Curr Opin Investig Drugs; 2005 Mar; 6(3):269-74. PubMed ID: 15816503
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy with ACE inhibitors and angiotensin-receptor blockers in heart failure.
    Scow DT, Smith EG, Shaughnessy AF.
    Am Fam Physician; 2003 Nov 01; 68(9):1795-8. PubMed ID: 14620599
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, or both in chronic heart failure.
    Young JB.
    Heart Fail Clin; 2005 Apr 01; 1(1):39-47. PubMed ID: 17386832
    [No Abstract] [Full Text] [Related]

  • 8. Anti-angiotensin therapy: new perspectives.
    Ramasubbu K, Mann DL, Deswal A.
    Cardiol Clin; 2007 Nov 01; 25(4):573-80; vi-vii. PubMed ID: 18063161
    [Abstract] [Full Text] [Related]

  • 9. [The role of ACE inhibitors and angiotensin receptor blockers in the treatment and prevention of chronic heart failure].
    Kárpáti P.
    Orv Hetil; 2005 May 01; 146(18):827-31. PubMed ID: 15926627
    [Abstract] [Full Text] [Related]

  • 10. ACE inhibitors or AT(1) receptor blockers in heart failure?
    Rydén L.
    Eur Heart J; 1999 Sep 01; 20(18):1287-9. PubMed ID: 10462459
    [No Abstract] [Full Text] [Related]

  • 11. The therapeutic role of RAS blockade in chronic heart failure.
    Werner CM, Böhm M.
    Ther Adv Cardiovasc Dis; 2008 Jun 01; 2(3):167-77. PubMed ID: 19124420
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 01; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 13. [ELITE II. AT1-blockers not better, but more tolerable than ACE-inhibitors].
    Berger D.
    Internist (Berl); 2000 Jan 01; 41(1):A37. PubMed ID: 10712087
    [No Abstract] [Full Text] [Related]

  • 14. Therapy with ACE inhibitors and ARBs in heart failure.
    Cayley WE.
    Am Fam Physician; 2004 Jul 15; 70(2):261. PubMed ID: 15291087
    [No Abstract] [Full Text] [Related]

  • 15. [ACE-inhibitors, AT1 receptor antagonists and diastolic dysfunction].
    Metra M, Nodari S, Bordonali T, Cagnazzi E, Boldi E, Dei Cas L.
    Cardiologia; 1999 Dec 15; 44 Suppl 1(Pt 1):53-8. PubMed ID: 12497882
    [No Abstract] [Full Text] [Related]

  • 16. Combination of ARB and ACE inhibitors in heart failure patients.
    Wexler R, Feldman D.
    Am Fam Physician; 2009 Mar 15; 79(6):454; author reply 456. PubMed ID: 19323357
    [No Abstract] [Full Text] [Related]

  • 17. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G, Gorini M, Maggioni AP, Di Lenarda A, Area Scompenso ANMCO, Firenze.
    G Ital Cardiol (Rome); 2007 Feb 15; 8(2):102-6. PubMed ID: 17402354
    [Abstract] [Full Text] [Related]

  • 18. [Antihypertensive therapy using a combination of angiotensin-1 receptor inhibitors and angiotensin-converting enzyme inhibitors].
    Schute L.
    Dtsch Med Wochenschr; 1998 Oct 23; 123(43):1295. PubMed ID: 9818002
    [No Abstract] [Full Text] [Related]

  • 19. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA, VATTC Trial.
    J Natl Cancer Inst; 2008 Sep 03; 100(17):1223-32. PubMed ID: 18728281
    [Abstract] [Full Text] [Related]

  • 20. [Use of angiotensin II receptor antagonists in the treatment of patients with chronic heart failure].
    Martynov AI, Vasiuk IuA, Krikunov PV, Khadzagova AB, Iushchuk EN, Sologub KN.
    Ter Arkh; 2001 Sep 03; 73(8):84-8. PubMed ID: 11599279
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.